Your browser doesn't support javascript.
loading
Designing phase II clinical trials to target subgroup of interest in a heterogeneous population: A case study using an R package.
Cabarrou, B; Sfumato, P; Leconte, E; Boher, J M; Filleron, T.
Affiliation
  • Cabarrou B; Institut Claudius Regaud-IUCT-O. Biostatistics Unit, Toulouse, France.
  • Sfumato P; Institut Paoli Calmettes. Biostatistics Unit, Marseille, France.
  • Leconte E; TSE-R, Toulouse, France.
  • Boher JM; Institut Paoli Calmettes. Biostatistics Unit, Marseille, France; Aix Marseille University, INSERM, IRD, SESSTIM, Marseille, France.
  • Filleron T; Institut Claudius Regaud-IUCT-O. Biostatistics Unit, Toulouse, France. Electronic address: filleron.thomas@iuct-oncopole.fr.
Comput Biol Med ; 100: 239-246, 2018 09 01.
Article in En | MEDLINE | ID: mdl-30055524
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Clinical Trials, Phase II as Topic / Neoplasms Limits: Humans Language: En Journal: Comput Biol Med Year: 2018 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Clinical Trials, Phase II as Topic / Neoplasms Limits: Humans Language: En Journal: Comput Biol Med Year: 2018 Document type: Article Affiliation country: France Country of publication: United States